CompanyTrack
G

GLIALIGN LIMITED

Active London

Research and experimental development on biotechnology

0 employees Website
Life sciences and medical technology Research and experimental development on biotechnology
G

GLIALIGN LIMITED

Research and experimental development on biotechnology

Founded 14 May 2016 Active London, England 0 employees glialign.com
Life sciences and medical technology Research and experimental development on biotechnology
Accounts Submitted 28 Feb 2025
Confirmation Statement Submitted 29 May 2025
Net assets £1.57K £4.50K 2024 year on year
Total assets £2.06K £4.49K 2024 year on year
Total Liabilities £483.00 £14.00 2024 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

90 Tottenham Court Road London W1T 4TJ England

Office ()

London, England, United Kingdom, Europe

Website

glialign.com

Credit Report

Discover GLIALIGN LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2022–2024)

Cash in Bank

N/A

Net Assets

£1.57k

Decreased by £4.50k (-74%)

Total Liabilities

£483.00

Increased by £14.00 (+3%)

Turnover

N/A

Employees

N/A

Debt Ratio

23%

Increased by 16 (+229%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

1 Allotment 40,000 Shares £40k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 Aug 201940,000£40k£1

Officers

Officers

2 active 1 resigned
Status
Caitriona Marie O' RourkeDirectorIrishEngland391 Mar 2024Active
John David SindenDirectorAustralianUnited Kingdom7414 May 2016Active

Shareholders

Shareholders (5)

Ucl Business Plc
34.8%
240,26028 May 2020
Ucl Technology Fund
17.4%
120,00028 May 2020
Uk Innovation & Science Seed Fund
10.1%
69,52528 May 2020

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Ucl Business Plc

United Kingdom

Active
Notified 17 Apr 2018
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

John David Sinden

Ceased 17 Apr 2018

Ceased

Group Structure

Group Structure

UCL BUSINESS LTD united kingdom
GLIALIGN LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
29 May 2025Confirmation StatementConfirmation statement made on 2025-05-16 with no updatesView(3 pages)
28 Feb 2025AccountsAnnual accounts made up to 2024-05-31View(3 pages)
24 May 2024Confirmation StatementConfirmation statement made on 2024-05-16 with no updatesView(3 pages)
6 Mar 2024OfficersTermination of Derek Reay as director on 2024-03-01View(1 page)
6 Mar 2024OfficersAppointment of Dr. Caitriona Marie O' Rourke as director on 2024-03-01View(2 pages)
29 May 2025 Confirmation Statement

Confirmation statement made on 2025-05-16 with no updates

28 Feb 2025 Accounts

Annual accounts made up to 2024-05-31

24 May 2024 Confirmation Statement

Confirmation statement made on 2024-05-16 with no updates

6 Mar 2024 Officers

Termination of Derek Reay as director on 2024-03-01

6 Mar 2024 Officers

Appointment of Dr. Caitriona Marie O' Rourke as director on 2024-03-01

Recent Activity

Latest Activity

Confirmation statement made on 2025-05-16 with no updates

8 months ago on 29 May 2025

Annual accounts made up to 2024-05-31

11 months ago on 28 Feb 2025

Confirmation statement made on 2024-05-16 with no updates

1 years ago on 24 May 2024

Termination of Derek Reay as director on 2024-03-01

1 years ago on 6 Mar 2024

Appointment of Dr. Caitriona Marie O' Rourke as director on 2024-03-01

1 years ago on 6 Mar 2024